FDA Is Expected to Lift Restriction on Peptides, Heeding RFK Jr.'s Wishes The New York Times When will the FDA reclassify BPC 157 to Category 1? Odds & Predictions FDA Targets GLP 1 and Peptide Compounding, Advertising and 'Research Use Only' Labeling The Unregulated World of Peptides: A Legal Minefield for Providers Holt Law Patients Using Wellness Peptides Have No Reliable Information About Whether They Are Safe or Effective, ECRI and ISMP Warn Is BPC 157 Legal? Understanding Its Status and Implications